FOXM1 and bronchopulmonary dysplasia: Xia et al. [47] revealed that FoxM1 is highly expressed in patients with bronchopulmonary dysplasia and neonatal mice with hyperoxia exposure, and selective deletion of FoxM1 in myeloid cells aggravates lung damage and inhibits alveologenesis.